A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin (SkyPASS) First published 31/01/2023 Last updated 18/03/2024 EU PAS number:EUPAS50671 Study Ongoing